| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.02. | Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 89 | GlobeNewswire (Europe) | SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule... ► Artikel lesen | |
| 03.02. | First Helium Inc.: First Helium Spuds 7-15 Exploration Well | 74 | GlobeNewswire (Europe) | CALGARY, Alberta, Feb. 03, 2025 (GLOBE NEWSWIRE) -- First Helium Inc. ("First Helium" or the "Company") (TSXV: HELI) (OTCQB: FHELF) (FRA: 2MC) today announced that it has begun drilling its high impact... ► Artikel lesen | |
| 03.02. | Revive Therapeutics Ltd.: Revive Therapeutics Announces Update on R&D Focus on Bucillamine for Infectious Diseases and Medical Countermeasures | 129 | GlobeNewswire (Europe) | TORONTO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research... ► Artikel lesen | |
| 03.02. | BellRing Brands, Inc.: BellRing Brands Reports Results for the First Quarter of Fiscal Year 2025; Raises Fiscal Year 2025 Outlook | 140 | GlobeNewswire (Europe) | ST. LOUIS, Feb. 03, 2025 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) ("BellRing"), a holding company operating in the global convenient nutrition category, today reported results for the... ► Artikel lesen | |
| 03.02. | RBB Bancorp Reports Fourth Quarter and Fiscal Year 2024 Earnings | 84 | GlobeNewswire (Europe) | LOS ANGELES, Feb. 03, 2025 (GLOBE NEWSWIRE) -- RBB Bancorp (NASDAQ:RBB) and its subsidiaries, Royal Business Bank (the "Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein... ► Artikel lesen | |
| 03.02. | DMG Blockchain Solutions Inc.: DMG Blockchain Solutions Announces Preliminary January Mining Results | 194 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB: DMGGF) (FRANKFURT: 6AX) ("DMG" or the "Company"), a vertically integrated blockchain... ► Artikel lesen | |
| 03.02. | United States Lime & Minerals, Inc.: United States Lime & Minerals Reports Fourth Quarter and Full Year 2024 Results and Declares Increased Regular Quarterly Cash Dividend | 112 | GlobeNewswire (Europe) | DALLAS, Feb. 03, 2025 (GLOBE NEWSWIRE) -- United States Lime & Minerals, Inc. (NASDAQ: USLM) today reported fourth quarter and full year 2024 results: The Company's revenues in the fourth quarter... ► Artikel lesen | |
| 03.02. | Cabot Corporation: Cabot Corp Reports First Quarter Fiscal 2025 Results | 94 | GlobeNewswire (Europe) | BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced results for its first quarter of fiscal year 2025. Key Highlights Diluted EPS of $1.67 and Adjusted EPS of... ► Artikel lesen | |
| 03.02. | Farouq Tuweiq to Succeed Daniel Bernstein as CEO of Bel Fuse Inc. in May 2025 | 88 | GlobeNewswire (Europe) | WEST ORANGE, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Bel Fuse Inc. (Nasdaq: BELFA and BELFB) ("Bel" or the "Company") today announced an upcoming transition in the Chief... ► Artikel lesen | |
| 03.02. | Xilio Therapeutics, Inc.: Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 39 | GlobeNewswire (Europe) | WALTHAM, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies... ► Artikel lesen | |
| 03.02. | Ingersoll Rand Continues Momentum on Inorganic Growth in 2025 | 211 | GlobeNewswire (Europe) | Acquisition extends company's capabilities in wastewater treatment, a key high-growth, sustainable end marketEnables Ingersoll Rand to provide more comprehensive wastewater treatment solutions, allowing... ► Artikel lesen | |
| 03.02. | J & J Snack Foods Corp.: J & J Snack Foods Reports Fiscal 2025 First Quarter Revenue Growth of 4.1% to $362.6M | 46 | GlobeNewswire (Europe) | MOUNT LAUREL, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- J & J Snack Foods Corp. (NASDAQ: JJSF) (the "Company") today reported financial results for the first quarter ended December 28, 2024. First... ► Artikel lesen | |
| 03.02. | Fabrinet Announces Second Quarter Fiscal Year 2025 Financial Results | 111 | GlobeNewswire (Europe) | BANGKOK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to... ► Artikel lesen | |
| 03.02. | NXP Semiconductors N.V.: NXP Semiconductors Reports Fourth Quarter and Full-Year 2024 Results | 64 | GlobeNewswire (Europe) | EINDHOVEN, The Netherlands, Feb. 03, 2025 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) today reported financial results for the fourth quarter and full-year, which ended December 31... ► Artikel lesen | |
| 03.02. | Universe Pharmaceuticals INC.: Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request | 115 | GlobeNewswire (Europe) | Ji'an, Jiangxi, China, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company... ► Artikel lesen | |
| 03.02. | X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 62 | GlobeNewswire (Europe) | BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective... ► Artikel lesen | |
| 03.02. | Synaptics Incorporated: Synaptics Announces CEO Transition | 59 | GlobeNewswire (Europe) | Michael Hurlston Steps Down as President and CEO to Pursue Another OpportunityKen Rizvi, CFO and Senior Vice President, Appointed Interim CEOCompany Reports Preliminary Financial Results for Fiscal... ► Artikel lesen | |
| 03.02. | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 817 | GlobeNewswire (Europe) | BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on January 31, 2025... ► Artikel lesen | |
| 03.02. | Highwoods Properties, Inc.: Highwoods Announces Recent Investment and Financing Activity | 87 | GlobeNewswire (Europe) | RALEIGH, N.C., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) is today announcing investment and financing transactions that closed during the fourth quarter of 2024 and to... ► Artikel lesen | |
| 03.02. | Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) | 31 | GlobeNewswire (Europe) | FOSTER CITY, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| RHEINMETALL | 5.400 |
| RENK GROUP | 4.036 |
| NVIDIA | 3.542 |
| THYSSENKRUPP | 2.826 |
| HENSOLDT | 2.547 |
| BYD | 2.479 |
| BAYER | 2.138 |
| SUPER MICRO COMPUTER | 1.498 |
| TESLA | 1.480 |
| TUI | 1.187 |
| PALANTIR TECHNOLOGIES | 952 |
| XIAOMI | 931 |
| COMMERZBANK | 881 |
| VOLKSWAGEN | 880 |
| EVOTEC | 791 |
| AIXTRON SE | 778 |
| BASF | 778 |
| DEUTSCHE TELEKOM | 777 |
| MICROSTRATEGY | 759 |
| NEL | 740 |
| DEUTSCHE BANK | 732 |
| ALLIANZ | 705 |
| MERCEDES-BENZ | 657 |
| NORDEX | 606 |
| LEONARDO | 599 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
